Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. EPIC investigators.
Lefkovits J, Ivanhoe RJ, Califf RM, Bergelson BA, Anderson KM, Stoner GL, Weisman HF, Topol EJ. Lefkovits J, et al. Am J Cardiol. 1996 May 15;77(12):1045-51. doi: 10.1016/s0002-9149(96)00128-2. Am J Cardiol. 1996. PMID: 8644655 Clinical Trial.
Use of routine functional testing after percutaneous transluminal coronary angioplasty: results from the ROSETTA Registry.
Eisenberg MJ, Schechter D, Lefkovits J, Goudreau E, Deligonul U, Mak KH, Del Core M, Duerr R, Garzon PM, Huynh T, Smilovitch M, Sedlis S, Brown DL, Brieger D, Pilote L; ROSETTA Investigators. Eisenberg MJ, et al. Among authors: lefkovits j. Am Heart J. 2001 May;141(5):837-46. doi: 10.1067/mhj.2001.114373. Am Heart J. 2001. PMID: 11320375
Comparison of six-month outcomes of percutaneous transluminal coronary angioplasty in patients > or =75 with those <75 years of age (the ROSETTA registry).
Abenhaim HA, Eisenberg MJ, Schechter D, Lefkovits J, Goudreau E, Deligonul U, Mak K, Duerr R, Del Core M, Huynh T, Smilovitch M, Sedlis S, Brown DL, Brieger D; ROSETTA Investigators. Routine versus Selective Exercise Treadmill Testing after Angioplasty. Abenhaim HA, et al. Among authors: lefkovits j. Am J Cardiol. 2001 Jun 15;87(12):1392-5. doi: 10.1016/s0002-9149(01)01560-0. Am J Cardiol. 2001. PMID: 11397361 No abstract available.
Comparison of event and procedure rates following percutaneous transluminal coronary angioplasty in patients with and without previous coronary artery bypass graft surgery [the ROSETTA (Routine versus Selective Exercise Treadmill Testing after Angioplasty) Registry].
Garzon P, Sheppard R, Eisenberg MJ, Schechter D, Lefkovits J, Goudreau E, Mak KH, Brown DL; ROSETTA Investigators. Garzon P, et al. Among authors: lefkovits j. Am J Cardiol. 2002 Feb 1;89(3):251-6. doi: 10.1016/s0002-9149(01)02223-8. Am J Cardiol. 2002. PMID: 11809424
Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?
Nguyen MC, Lim YL, Walton A, Lefkovits J, Agnelli G, Goodman SG, Budaj A, Gulba DC, Allegrone J, Brieger D; GRACE Investigators. Nguyen MC, et al. Among authors: lefkovits j. Eur Heart J. 2007 Jul;28(14):1717-22. doi: 10.1093/eurheartj/ehm186. Epub 2007 Jun 11. Eur Heart J. 2007. PMID: 17562671
170 results